https://www.gsk.com/en-gb/media/press-releases/exdensur-depemokimab-approved-by-us-fda-for-the-treatment-of-severe-asthma/
0
0
12/16/25 at 11:02pm
Organization
Gsk.com
28 words
0
Comments
SWIFT data included reduction in exacerbations requiring hospitalisation and/or emergency department visits with depemokimab.
You are the first to view
Create an account
or login to join the discussion